CVE-2025-6512 | BDVDB-2026-283564 Detail

Bizerba SE & Co. KGBRAIN2

Description#

On a client with a non-admin user, a script can be integrated into a report. The reports could later be executed on the BRAIN2 server with administrator rights.

Impact#

Per CVSS v3.1: confidentiality impact high, integrity impact high, availability impact high. Attack vector: network.

Weaknesses#

CWE-94 Improper Control of Generation of Code ('Code Injection')

References#

https://www.bizerba.com/downloads/global/information-security/2025/bizerba-sa-2025-0004.pdf

Exploit#

No public exploit known

History#

Version 12025-06-23Record published in the CVE List.

Published

Published: 2025-06-23
Last modified: 2025-06-23

Vendor information

Vendor: Bizerba SE & Co. KG
Product: BRAIN2

All Bizerba SE & Co. KG vulnerabilities

Score

10.0 Critical

EPSS

less than 1%, Very Low

Estimated chance of exploitation in the next 30 days. EPSS percentile: 46.1.

KEV

Not listed in the CISA Known Exploited Vulnerabilities catalog.

Impact

Code Injection

Action

No specific action is recorded in the source data. Check the references for vendor guidance.

Affected Systems

Vulnerable
>= 0.0 and < 3.06
Fixed
3.06

Scoring System

CVSS v4.0

Not available

CVSS v3.1

10.0 Critical

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

Metric breakdown
Attack Vector	Network
Attack Complexity	Low
Privileges Required	None
User Interaction	None
Scope	Changed
Confidentiality	High
Integrity	High
Availability	High

CVSS v3.0

Not available

CVSS v2

Not available

Source: CVE List v5 (record); CISA KEV (kev, action); FIRST EPSS (epss).